The Effects of Polyunsaturated Omega-3 Fatty Acids (Lovaza) on Patients Taking Clopidogrel +/- Aspirin Who Have Suffered an Ischemic Stroke/TIA and/or Are Candidates for Neuroendovascular Stenting.
Phase of Trial: Phase 0
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Aspirin (Primary) ; Clopidogrel (Primary) ; Omega 3 fatty acids
- Indications Embolism and thrombosis; Stroke
- Focus Pharmacodynamics; Therapeutic Use
- 09 Feb 2012 New trial record